Description: Every year an AI topic goes through a hype cycle. Since 2022 and now in 2023 we continue to hear more about the ChatGPT models and how an everyday person is able to interact with AI. As more startups and applications are riding the hype, what does it all mean for our industry? Is this just a buzz or real? This talk intends to cover at a high level what are large language models, what does it mean for audit or regulatory space, and what might be some pitfalls or tolerance of error when it comes to selecting a right application for such models in insurance use cases.

Description: Come discuss how reinsurers can work side by side with insurer to better develop products, and lift in the areas that reinsurers have more experience, help matching products with distributions (or vice versa) and provide advanced technologies associated with tools and software. The speakers will also present Direct to Consumer plan from various points of view, i.e., distributors, carriers, and reinsurers. Some case studies will also be presented where traditional reinsurers and asset-intensive reinsurers helped insurers bring products to life.

Description: Back by popular demand, it is that time of year for this well-liked annual webcast. Get ready to hear from three expert speakers, who will be covering the latest considerations for the year's U.S. statutory financial reporting work. 2021 has proven to have been quite remarkable, providing many important topics to be discussed.

Description: A panel of leading reinsurance executivesprovide perspective on topics to include market capacity, cell and gene therapy, COVID-19's impact on results, syndication arrangements, mergers and acquisitions, and how reinsurers view a variety of risk transfer opportunities.

Description: Join us for a lively discussion on how accelerated underwriting (AU) practices have evolved over time and specifically because of COVID-19.

Description: Despite its significance, longevity risk in the U.S. market has historically received fairly little attention, especially in international comparison, but the tide seems to be turning.

Description: The cell and gene therapy marketplace is quickly evolving and continues to grow as a risk concern for governments, health plans, stop loss insurers and reinsurers. In this webinar, we discuss currently approved tissue, cell and gene therapies, the near-term pipeline, uptake considerations, case management processes, plan document and contract considerations, risk mitigation processes and programs, and network considerations.

Description: Learn about considerations and industry observed trends which cover different ways companies try to manage their inforce business in low and rapidly rising interest environments. You will explore M&A, block transaction, and offshore reinsurance solutions.

Description: This webcast will walk through several statistical methods for imputing race and ethnicity from U.S. datasets, highlighting their strengths and weaknesses, talking about how to use them and evaluating their accuracy, and telling you where you can get code packages as well as a free dataset to try the methods out.